CEO Mark Zuckerberg kicked off the company's annual Connect event in Menlo Park on Wednesday with a keynote that made one thing clear: Meta is going all-in on Muse. It's even coming to Meta's AI glasses.
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.